Sermorelin

Drug #1753

Sermorelin is a synthetic peptide used for the diagnosis of growth hormone deficiency. It has been invastigated as an adjunct to gonadotrophin therapy in the induction of ovulation.

← Previous drug Next drug →

Primary Characteristics

Non-proprietary name: Sermorelin.

Pharmacokinetics

None recorded.

Indications

Sermorelin is primarily indicated in conditions like Termination of pregnancy of 13-24 weeks gestation.

Contraindications

Sermorelin is contraindicated in conditions like Pregnancy, Breast feeding.

Dosage

Sermorelin's dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
0.25 mcg	0.25 mcg	Every 24h	SC	Sermorelin is given as Sermorelin acetate daily at bed time.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

2 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Sermorelin is known to cause more or less tolerable side effects which are usually transient. These include Facial flushing, Pain at injection site.

Warnings / Precautions

Sermorelin should be used with caution in patients with epilepsy; disccontinue growth hormone therapy 1-2 weeks before test; untreated hypothyroidism, antithyroid drugs; obesity, hyperglycaemia, elevated plasma fatty acids; avoid preparation which affect release of growth hormone (including those affecting release of somatostatin, insulin or glucocorticoidsand cyclo-oxygenase inhibitors such as aspirin and indometacin).

Interference in Pathology

Sermorelin may interfere in the diagnosis of Increased Alkaline Phosphatase Levels.

Available Brands

None recorded.

Storage Conditions

Sermorelin should be stored Inj.

Drug Classification

1.18.6 — Ovulation stimulants